.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Federal Trade Commission
US Department of Justice
Baxter
Express Scripts
Fuji
Cantor Fitzgerald
Covington
Argus Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022180

« Back to Dashboard

NDA 022180 describes FERAHEME, which is a drug marketed by Amag Pharms Inc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the FERAHEME profile page.

The generic ingredient in FERAHEME is ferumoxytol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ferumoxytol profile page.

Summary for 022180

Tradename:1
Applicant:1
Ingredient:1
Patents:6
Formulation / Manufacturing:see details

Pharmacology for NDA: 022180

Ingredient-typeIron

Suppliers and Packaging for NDA: 022180

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180 NDA AMAG Pharmaceuticals, Inc. 59338-775 59338-775-01 1 VIAL, SINGLE-USE in 1 CARTON (59338-775-01) > 17 mL in 1 VIAL, SINGLE-USE
FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180 NDA AMAG Pharmaceuticals, Inc. 59338-775 59338-775-10 10 VIAL, SINGLE-USE in 1 CARTON (59338-775-10) > 17 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrengthEQ 510MG IRON/17ML (EQ 30MG IRON/ML)
Approval Date:Jun 30, 2009TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jun 30, 2023Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Mar 8, 2020Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Mar 8, 2020Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Teva
UBS
Queensland Health
Cipla
Express Scripts
Baxter
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot